[Federal Register: June 11, 2003 (Volume 68, Number 112)] [Rules and Regulations] [Page 34796-34797] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr11jn03-10] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 601 [Docket No. 91N-0278] New Drug, Antibiotic, and Biological Drug Product Regulations; Accelerated Approval; Technical Amendment AGENCY: Food and Drug Administration, HHS. ACTION: Final rule; technical amendment. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is amending the biologics regulations to correct certain errors that were incorporated into the regulations. This action is being taken to improve the accuracy of the regulations. DATES: This rule is effective June 11, 2003. FOR FURTHER INFORMATION CONTACT: Stephen M. Ripley, Center for Biologics Evaluation and Research (HFM-17), Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852-1448, 301-827- 6210. SUPPLEMENTARY INFORMATION: FDA has discovered certain errors that were inadvertently included in the agency's codified regulations for part 601 (21 CFR part 601). In the Federal Register of December 11, 1992 (57 FR 58942), we published a final rule that, among other things, established subpart E of part 601, which encompasses Sec. Sec. 601.40 through 601.46. Currently, Sec. 601.43(a) refers to Sec. 601.40, instead of the correct Sec. 601.41; Sec. 601.43(b) refers to Sec. 601.40, instead of the correct Sec. 601.42. Accordingly, we are amending Sec. 601.43(a) by replacing the incorrect reference to Sec. 601.40 with a reference to Sec. 601.41, and we are amending Sec. 601.43(b) by replacing the incorrect reference to Sec. 601.40 with a reference to Sec. 601.42. Publication of this document constitutes final action under the Administrative Procedure Act (5 U.S.C. 553). FDA has determined that notice and public comment are unnecessary because this amendment is nonsubstantive. List of Subjects in 21 CFR Part 601 Administrative practice and procedure, Biologics, Confidential business information. 0 Therefore, under the Federal Food, Drug, and Cosmetic Act, and Public Health Service Act, and under authority delegated to the Commissioner of Food and Drugs, 21 CFR part 601 is amended as follows: [[Page 34797]] PART 601--LICENSING 0 1. The authority citation for 21 CFR part 601 continues to read as follows: Authority: 15 U.S.C. 1451-1561; 21 U.S.C. 321, 351, 352, 353, 355, 356B, 360, 360c-360f, 360h-360j, 371, 374, 379e, 381; 42 U.S.C. 216, 241, 262, 263, 264; sec. 122, Pub. L. 105-115, 111 Stat. 2322 (21 U.S.C. 355 note). Sec. 601.43 [Amended] 0 2. Section 601.43 Withdrawal procedures is amended in the introductory text of paragraph (a) by removing ``Sec. Sec. 601.40 and 640.42'' and adding in its place ``Sec. 601.41 or Sec. 601.42'', and in paragraph (b) by removing ``Sec. 601.40 or Sec. 601.41'' and adding in its place ``Sec. 601.41 or Sec. 601.42''. Dated: June 4, 2003. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. 03-14621 Filed 6-10-03; 8:45 am] BILLING CODE 4160-01-S